These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 25434600)
21. Activation of Shigella flexneri type 3 secretion requires a host-induced conformational change to the translocon pore. Russo BC; Duncan JK; Wiscovitch AL; Hachey AC; Goldberg MB PLoS Pathog; 2019 Nov; 15(11):e1007928. PubMed ID: 31725799 [TBL] [Abstract][Full Text] [Related]
22. 34 kDa MOMP of Shigella flexneri promotes TLR2 mediated macrophage activation with the engagement of NF-kappaB and p38 MAP kinase signaling. Pore D; Mahata N; Pal A; Chakrabarti MK Mol Immunol; 2010 May; 47(9):1739-46. PubMed ID: 20347487 [TBL] [Abstract][Full Text] [Related]
23. A human pathogenic bacterium Shigella proliferates in plants through adoption of type III effectors for shigellosis. Jo SH; Lee J; Park E; Kim DW; Lee DH; Ryu CM; Choi D; Park JM Plant Cell Environ; 2019 Nov; 42(11):2962-2978. PubMed ID: 31250458 [TBL] [Abstract][Full Text] [Related]
24. Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen. Lucchini S; Liu H; Jin Q; Hinton JC; Yu J Infect Immun; 2005 Jan; 73(1):88-102. PubMed ID: 15618144 [TBL] [Abstract][Full Text] [Related]
25. Delivery of biologically active anti-inflammatory cytokines IL-10 and IL-1ra in vivo by the Shigella type III secretion apparatus. Chamekh M; Phalipon A; Quertainmont R; Salmon I; Sansonetti P; Allaoui A J Immunol; 2008 Mar; 180(6):4292-8. PubMed ID: 18322242 [TBL] [Abstract][Full Text] [Related]
26. Shigella effector IpaH9.8 binds to a splicing factor U2AF(35) to modulate host immune responses. Okuda J; Toyotome T; Kataoka N; Ohno M; Abe H; Shimura Y; Seyedarabi A; Pickersgill R; Sasakawa C Biochem Biophys Res Commun; 2005 Jul; 333(2):531-9. PubMed ID: 15950937 [TBL] [Abstract][Full Text] [Related]
27. Apyrase, the product of the virulence plasmid-encoded phoN2 (apy) gene of Shigella flexneri, is necessary for proper unipolar IcsA localization and for efficient intercellular spread. Santapaola D; Del Chierico F; Petrucca A; Uzzau S; Casalino M; Colonna B; Sessa R; Berlutti F; Nicoletti M J Bacteriol; 2006 Feb; 188(4):1620-7. PubMed ID: 16452446 [TBL] [Abstract][Full Text] [Related]
28. Shigella effector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation. Otsubo R; Mimuro H; Ashida H; Hamazaki J; Murata S; Sasakawa C Cell Microbiol; 2019 Mar; 21(3):e12974. PubMed ID: 30414351 [TBL] [Abstract][Full Text] [Related]
30. Shigella infection interferes with SUMOylation and increases PML-NB number. Sidik SM; Salsman J; Dellaire G; Rohde JR PLoS One; 2015; 10(4):e0122585. PubMed ID: 25848798 [TBL] [Abstract][Full Text] [Related]
31. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria. Ashida H; Sasakawa C Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450 [TBL] [Abstract][Full Text] [Related]
32. The phosphothreonine lyase activity of a bacterial type III effector family. Li H; Xu H; Zhou Y; Zhang J; Long C; Li S; Chen S; Zhou JM; Shao F Science; 2007 Feb; 315(5814):1000-3. PubMed ID: 17303758 [TBL] [Abstract][Full Text] [Related]
33. Cell-cell propagation of NF-κB transcription factor and MAP kinase activation amplifies innate immunity against bacterial infection. Kasper CA; Sorg I; Schmutz C; Tschon T; Wischnewski H; Kim ML; Arrieumerlou C Immunity; 2010 Nov; 33(5):804-16. PubMed ID: 21093316 [TBL] [Abstract][Full Text] [Related]
34. Interfacial amino acids support Spa47 oligomerization and shigella type three secretion system activation. Demler HJ; Case HB; Morales Y; Bernard AR; Johnson SJ; Dickenson NE Proteins; 2019 Nov; 87(11):931-942. PubMed ID: 31162724 [TBL] [Abstract][Full Text] [Related]